NCT00312494 - 3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects | Biotech Hunter

Enrollment

680

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Bipolar Disorder

Interventions

DRUG

Placebo

Placebo with mood stabilizer (either lithium or divalproex)

DRUG

Ziprasidone

Flexible dosing, 20-40mg BID, with a mood stabilizer (either lithium or divalproex)

DRUG

Ziprasidone

Flexible dosing, 60-80mg BID, with a mood stabilizer (either lithium or divalproex)

Trial Locations (66)

10523

Pfizer Investigational Site, Elmsford

11516

Pfizer Investigational Site, Cedarhurst

11701

Pfizer Investigational Site, Amityville

14215

Pfizer Investigational Site, Buffalo

19149

Pfizer Investigational Site, Philadelphia

21061

Pfizer Investigational Site, Glen Burnie

23229

Pfizer Investigational Site, Richmond

23230

Pfizer Investigational Site, Richmond

27609

Pfizer Investigational Site, Raleigh

29405

Pfizer Investigational Site, Charleston

30308

Pfizer Investigational Site, Atlanta

32607

Pfizer Investigational Site, Gainesville

32720

Pfizer Investigational Site, DeLand

33021

Pfizer Investigational Site, Hollywood

33119

Pfizer Investigational Site, Lauderhill

33161

Pfizer Investigational Site, North Miami

33301

Pfizer Investigational Site, Fort Lauderdale

33308

Pfizer Investigational Site, Fort Lauderdale

36303

Pfizer Investigational Site, Dothan

39232

Pfizer Investigational Site, Flowood

44113

Pfizer Investigational Site, Cleveland

45219

Pfizer Investigational Site, Cincinnati

45220

Pfizer Investigational Site, Cincinnati

46143

Pfizer Investigational Site, Greenwood

60016

Pfizer Investigational Site, Des Plaines

60169

Pfizer Investigational Site, Hoffman Estates

60194

Pfizer Investigational Site, Hoffman Estates

Pfizer Investigational Site, Schaumburg

63118

Pfizer Investigational Site, St Louis

63128

Pfizer Investigational Site, St Louis

63304

Pfizer Investigational Site, Saint Charles

64133

Pfizer Investigational Site, Kansas City

66206

Pfizer Investigational Site, Prairie Village

72211

Pfizer Investigational Site, Little Rock

73112

Pfizer Investigational Site, Oklahoma City

75024

Pfizer Investigational Site, Plano

75062

Pfizer Investigational Site, Irving

75228

Pfizer Investigational Site, Dallas

85251

Pfizer Investigational Site, Scottsdale

89102

Pfizer Investigational Site, Las Vegas

89103

Pfizer Investigational Site, Las Vegas

90057

Pfizer Investigational Site, Los Angeles

90061

Pfizer Investigational Site, Los Angeles

90505

Pfizer Investigational Site, Torrance

90703

Pfizer Investigational Site, Cerritos

91204

Pfizer Investigational Site, Glendale

91950

Pfizer Investigational Site, National City

92025

Pfizer Investigational Site, Escondido

92056

Pfizer Investigational Site, Oceanside

92114

Pfizer Investigational Site, San Diego

92120

Pfizer Investigational Site, San Diego

92126

Pfizer Investigational Site, San Diego

92626

Pfizer Investigational Site, Costa Mesa

92647

Pfizer Investigational Site, Huntington Beach

96813

Pfizer Investigational Site, Honolulu

98004

Pfizer Investigational Site, Bellevue

98033

Pfizer Investigational Site, Kirkland

06106

Pfizer Investigational Site, Hartford

06050

Pfizer Investigational Site, New Britain

32256-2006

Pfizer Investigational Site, Jacksonville

63044-2588

Pfizer Investigational Site, St Louis

08021

Pfizer Investigational Site, Clementon

08540

Pfizer Investigational Site, Princeton

45267-0559

Pfizer Investigational Site, Cincinnati

78229-3900

Pfizer Investigational Site, San Antonio

78259-3509

Pfizer Investigational Site, San Antonio

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY